QuidelOrtho Corporation launched a Certified Analyzer Program, an initiative designed to expand access to high-quality diagnostic testing in rural and community hospitals across the United States. This program targets clinics, physician office labs, and small hospitals with fewer than 100 beds.
The program offers certified VITROS™ analyzers, which are known for their reliability and quality results, along with award-winning service, at a reduced cost. This approach aims to make advanced diagnostic capabilities more accessible to underserved areas.
This strategic move is expected to increase the installed base of QuidelOrtho's analyzers in new market segments, driving higher-margin recurring revenue from associated consumables and reagents. It underscores the company's commitment to broadening its market reach and supporting patient care in diverse healthcare settings.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.